Medicenna Therapeutics Corp Analysis
| Analyst Ratings |
|
Average Target Price
|
2.50
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-06-30
|
-0.04
|
-0.04
|
0.00
|
0.00%
|
|
2024-03-31
|
-0.05
|
-0.20
|
-0.15
|
-300.00%
|
|
2023-12-31
|
-0.07
|
-0.07
|
0.00
|
0.00%
|
|
2023-09-30
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2023-06-30
|
-0.05
|
-0.03
|
0.02
|
40.00%
|
|
2023-03-31
|
-0.07
|
-0.04
|
0.03
|
42.86%
|
|
2020-09-30
|
0.00
|
-0.06
|
0.00
|
0.00%
|
|
2020-06-30
|
-0.04
|
-0.05
|
-0.01
|
-25.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-06-30
|
-0.04
|
|
2024-03-31
|
-0.35
|
|
2023-03-31
|
-0.15
|
|
2020-03-31
|
-0.26
|
|
2019-03-31
|
-0.14
|
|
2018-03-31
|
-0.20
|